| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |